R. O’Connor

Metabolic rewiring of macrophages by CpG potentiates clearance of cancer cells and overcomes tumor-expressed CD47−mediated ‘don’t-eat-me’ signal

S. Trefely, N. Snyder, G. Beatty, 2019, Nature Immunology.

Rapid manufacturing of non-activated potent CAR T cells

F. Bushman, Feng Shen, V. A. Cantu, 2022, Nature Biomedical Engineering.

Metabolic and epigenetic orchestration of (CAR) T cell fate and function.

H. Mirzaei, S. Ghassemi, Pardis Shahabinejad, 2022, Cancer letters.

Targeting PARP11 to avert immunosuppression and improve CAR T therapy in solid tumors

P. Yu, A. Minn, S. Fuchs, 2022, Nature Cancer.

Humanized Chimeric Antigen Receptor (CAR) T cells

P. S. Kozani, Pooria Safarzadeh Kozani, Roddy S O'Connor, 2021, Journal of cancer immunology.

Enhancing CAR T function with the engineered secretion of C. perfringens neuraminidase

Zev A. Binder, D. O’Rourke, Edward Song, 2021, Molecular therapy : the journal of the American Society of Gene Therapy.

In Vitro Induction of Human Regulatory T Cells Using Conditions of Low Tryptophan Plus Kynurenines

J. Wagner, D. Munn, B. Levine, 2017, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Nicotinamide enhances natural killer cell function and yields remissions in patients with non-Hodgkin lymphoma

Justin H Hwang, Cheng-Ying Wu, N. Snyder, 2023, Science Translational Medicine.